Notably, the beneficial effects of chrysophanol on reducing FBG, GGT, and ITT were largely diminished in SIRT6 FKO obese mice, suggesting a critical role of SIRT6 in mediating the effects of chrysophanol in preventing obesity, improving glucose tolerance and insulin sensitivity. Here, SIRT6 is linked to Obesity.